This session describes which sedative agent(s) to use, when and why, for the critically-ill patient.

This session will describe how pain in the intensive care unit (ICU) is multi-factorial and difficult to assess. It will show how potentially useful drugs may also have adverse effects and how non-pharmacological treatment effects must be maximized. <br>

This session covers the key considerations when using neuromuscular blockers in the critically-ill patient. It will cover their main indications, monitoring and complications in the critical care unit.

This session describes the diagnosis, treatment and pathophysiology of delirium in critical care patients.

This session describes a rational approach to the use of intravenous fluids in critical care based on a modern understanding of the physiology of fluid homeostasis, and on the available evidence in this area.

This session describes the different classes of organisms that can cause infection and highlights some of the common pathogens seen on ICU.

This session describes the commonly occurring nosocomial infections in critical care and the common sites of infection. A description of standard infection control practices, emphasizing the importance of adhering to these procedures, is provided.

This session will revise the definition, classification and mechanism of action of commonly used antibiotics. The principles of antibiotic use in a variety of clinical situations will be covered and the problem of antimicrobial resistance to antibiotics w

This session contains a link to the BJA Education article followed by a series of self assessment multiple choice questions.<br><br>The article will open in a new window or tab depending on your browser.<br><br> CPD credits are awarded by the RCoA for the

This session will discuss the pathophysiology, clinical features and management of both hyponatraemia and hypernatraemia in critically-ill patients.